R. Prussick, “Patients With Psoriasis Treated With Brodalumab: A Pooled Post Hoc Analysis of a Marker of Liver Inflammation in Individuals With Potential Indicators of Early Nonalcoholic Fatty Liver Disease”, J of Skin, vol. 3, p. S20, Nov. 2019.